IFNA2 and neoplasm: In the current study, we confirmed the tumor inhibition effect of IFN-α2a-NGR in vivo and found that it was 3× more potent than IFN-α2a in elicting its anti-tumor effects in A549- and SPC-A-1- bearing mice.